A protocol for a randomized trial evaluating the role of carbon‐ion radiation therapy plus camrelizumab for patients with locoregionally recurrent nasopharyngeal carcinoma

A protocol for a randomized trial evaluating the role of carbon‐ion radiation therapy plus camrelizumab for patients with locoregionally recurrent nasopharyngeal carcinoma

Abstract Purpose Management of locoregionally recurrent nasopharyngeal carcinoma (LR NPC) is difficult. Although carbon‐ion radiation therapy (CIRT) could substantially improve the overall survival (OS) of those patients, around 40% of the patients may still develop local failure. Further improvemen...

Full description

Bibliographic Details
Main Authors: Jiyi Hu, Qingting Huang, Weixu Hu, Jing Gao, Jing Yang, Haojiong Zhang, Jiade Jay Lu, Lin Kong
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Cancer Medicine
Subjects:
camrelizumab
carbon ion
radiotherapy (RT)
randomized trial
recurrent nasopharyngeal carcinoma
Online Access:https://doi.org/10.1002/cam4.6742

Similar Items

Similar Items